The most parsimonious explanation for our data is that p11 acts as a regulator of the surface expression of GluN2A in DRN, so its reduction might mediate CSDS-induced depression-like phenotypes by inhibiting the excitability of serotonergic neurons in DRN. The gene discussed is S100A10; the disease is depressive symptom measurement.